#BEGIN_DRUGCARD DB02111

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C4H3NO4

# Chemical_IUPAC_Name:
3-hydroxy-1,2-oxazole-4-carboxylic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
3-Hydroxyisoxazole-4-Carboxylic Acid

# HET_ID:
GAG

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C4H3NO4/c6-3-2(4(7)8)1-9-5-3/h1H,(H,5,6)(H,7,8)

# InChI_Key:
InChIKey=JLPHBZYAQYOJND-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2111

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
129.0709

# Molecular_Weight_Mono:
129.006207589

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1T25

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.6

# Predicted_LogS:
-0.47

# Predicted_Water_Solubility:
4.39e+01 g/l

# Primary_Accession_No:
DB02111

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
448651

# PubChem_Substance_ID:
46508407

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01545

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
OC(=O)C1=CON=C1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:48 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M93720

# Drug_Target_1_GenBank_ID_Protein:
294165

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>951 bp
ATGGCACCAAAAGCAAAAATCGTTTTAGTTGGCTCAGGTATGATTGGAGGAGTAATGGCT
ACCTTAATTGTTCAGAAAAATTTAGGAGATGTAGTTTTGTTCGATATTGTAAAGAACATG
CCACATGGAAAAGCTTTAGATACATCTCATACTAATGTTATGGCATATTCAAATTGCAAA
GTAAGTGGTTCAAACACTTATGACGATTTGGCTGGAGCAGATGTAGTAATAGTAACAGCT
GGATTTACCAAGGCCCCAGGAAAGAGTGACAAAGAATGGAATAGAGATGATTTATTACCA
TTAAACAACAAGATTATGATTGAAATTGGTGGTCATATTAAGAAGAATTGTCCAAATGCT
TTTATTATTGTTGTAACAAACCCAGTAGATGTTATGGTACAATTATTACATCAACATTCA
GGTGTTCCTAAAAACAAGATTATTGGTTTAGGTGGTGTATTAGATACATCAAGATTGAAG
TATTACATATCTCAGAAATTAAATGTATGCCCAAGAGATGTAAATGCACACATTGTAGGT
GCTCATGGAAATAAAATGGTTCTTTTAAAAAGATACATTACTGTAGGTGGTATCCCTTTA
CAAGAATTTATTAATAACAAGTTAATTTCTGATGCTGAATTAGAAGCTATATTTGATAGA
ACTGTTAATACTGCATTAGAAATTGTAAACTTACATGCATCACCATATGTTGCACCAGCT
GCTGCTATTATCGAAATGGCTGAATCCTACTTAAAAGATTTGAAAAAAGTATTAATTTGC
TCAACCTTGTTAGAAGGACAATATGGACACTCCGATATATTCGGTGGTACACCTGTTGTT
TTAGGTGCTAATGGTGTTGAACAAGTTATCGAATTACAATTAAATAGTGAGGAAAAAGCT
AAATTTGATGAAGCCATAGCTGAAACTAAGAGAATGAAGGCATTAGCTTAA

# Drug_Target_1_General_Function:
Energy production and conversion

# Drug_Target_1_General_References:
10187806	Read JA, Wilkinson KW, Tranter R, Sessions RB, Brady RL: Chloroquine binds in the cofactor binding site of Plasmodium falciparum lactate dehydrogenase. J Biol Chem. 1999 Apr 9;274(15):10213-8.
8515777	Bzik DJ, Fox BA, Gonyer K: Expression of Plasmodium falciparum lactate dehydrogenase in Escherichia coli. Mol Biochem Parasitol. 1993 May;59(1):155-66.
8901865	Dunn CR, Banfield MJ, Barker JJ, Higham CW, Moreton KM, Turgut-Balik D, Brady RL, Holbrook JJ: The structure of lactate dehydrogenase from Plasmodium falciparum reveals a new target for anti-malarial design. Nat Struct Biol. 1996 Nov;3(11):912-5.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2641

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
34108

# Drug_Target_1_Name:
L-lactate dehydrogenase

# Drug_Target_1_Number_of_Residues:
316

# Drug_Target_1_PDB_ID:
1T2D

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00056	Ldh_1_N
PF02866	Ldh_1_C

# Drug_Target_1_Protein_Sequence:
>L-lactate dehydrogenase
MAPKAKIVLVGSGMIGGVMATLIVQKNLGDVVLFDIVKNMPHGKALDTSHTNVMAYSNCK
VSGSNTYDDLAGADVVIVTAGFTKAPGKSDKEWNRDDLLPLNNKIMIEIGGHIKKNCPNA
FIIVVTNPVDVMVQLLHQHSGVPKNKIIGLGGVLDTSRLKYYISQKLNVCPRDVNAHIVG
AHGNKMVLLKRYITVGGIPLQEFINNKLISDAELEAIFDRTVNTALEIVNLHASPYVAPA
AAIIEMAESYLKDLKKVLICSTLLEGQYGHSDIFGGTPVVLGANGVEQVIELQLNSEEKA
KFDEAIAETKRMKALA

# Drug_Target_1_Reaction:
(S)-lactate + NAD+ = pyruvate + NADH + H+

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
(S)-lactate + NAD(+) = pyruvate + NADH

# Drug_Target_1_SwissProt_ID:
Q27743

# Drug_Target_1_SwissProt_Name:
LDH_PLAFD

# Drug_Target_1_Synonyms:
EC 1.1.1.27
LDH-P

# Drug_Target_1_Theoretical_pI:
7.63

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02111
